Wells Fargo & Company Miromatrix Medical Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.19 - $1.94 $14 - $23	-12 Reduced 7.27%	153 $0
Q2 2023 Aug 15, 2023	BUY	$0.92 - $2.03 $46 - $103	51 Added 44.74%	165 $0
Q1 2023 May 12, 2023	BUY	$1.45 - $3.49 $2 - $6	2 Added 1.79%	114 $0
Q4 2022 Feb 13, 2023	BUY	$2.5 - $4.44 $7 - $13	3 Added 2.75%	112 $0
Q3 2022 Nov 14, 2022	BUY	$2.27 - $4.86 $145 - $311	64 Added 142.22%	109 $0
Q2 2022 Aug 12, 2022	BUY	$3.36 - $4.32 $13 - $17	4 Added 9.76%	45 $0
Q4 2021 Feb 14, 2022	BUY	$4.45 - $9.4 $53 - $112	12 Added 41.38%	41 $0
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.75 $191 - $369	29 New	29 $0

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.